Selux Diagnostics Receives FDA Clearance on Their Gram-Negative Panel, Expanding the Antibiotic Menu for Its Next Generation Phenotyping System for Rapid AST
Fighting a Public Health Crisis with Innovation: Eric Stern, PhD, and Dr. Jim Lewis of Selux Diagnostics on Bleeding Edge Advances in AMR
Dr. James S. Lewis II, Antibiotic Susceptibility Test expert, joins as Chair of Selux Diagnostics’ Clinical Advisory Board
Science is a Puzzle: Selux Diagnostics Director of Research and Development Kelly Flentie On Collaboration, Idea Diversity, and Solving One of the Biggest Medical Problems of Our Time
